NCT06906341 2026-04-14
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Corcept Therapeutics
Phase 2 Recruiting
Clinical Trials
65 trialsNCT07514494 2026-04-07
PrimPIPAC
Moscow Regional Oncological Dispensary
Phase 2 Recruiting
NCT04779554 2026-04-01
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
University of Kentucky
Phase 2 Recruiting
NCT06504147 2026-03-11
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
Oncoinvent Solutions AS
Phase 2 Recruiting
NCT07282834 2026-02-27
Charlie-2
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Phase 2 Recruiting
NCT03875144 2026-02-09
MESOTIP
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Suspended
NCT04762953 2026-02-03
STOPGAP
University of California, Irvine
Phase 2 Active not recruiting
NCT04107077 2025-10-07
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
University of Chicago
Phase 2 Recruiting
NCT03127774 2025-10-03
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
Columbia University
Phase 2 Recruiting
NCT00766142 2025-08-29
COCHISE
Institut Bergonié
Phase 2 Terminated
NCT05185947 2025-03-07
Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Active not recruiting
NCT04034251 2025-02-03
Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT04950166 2024-11-08
A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets
OncoNano Medicine, Inc.
Phase 2 Completed
NCT02040142 2024-10-24
HIPEC for Peritoneal Carcinomatosis
Albert Einstein College of Medicine
Phase 2 Completed
NCT02891447 2024-09-19
Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT05913674 2024-08-21
Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
Ciusss de L'Est de l'Île de Montréal
Phase 2 Recruiting
NCT05687617 2024-04-02
Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma.
Laval University
Phase 2 Terminated
NCT04840264 2024-03-18
Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2 Recruiting
NCT05371223 2024-02-26
Nab-PIPAC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2 Unknown
NCT04826432 2024-02-08
PASIREOCHIP
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Terminated
NCT02399410 2024-01-30
Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis
University Hospital, Ghent
Phase 2 Completed
NCT02567253 2023-11-27
OvIP1
University Hospital, Ghent
Phase 2 Completed
NCT03073694 2023-06-09
Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis
University of Kansas Medical Center
Phase 2 Unknown
NCT05541146 2023-03-23
Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis
Instituto do Cancer do Estado de São Paulo
Phase 2 Unknown
NCT01575730 2022-12-15
Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis
University Hospital, Ghent
Phase 2 Completed
NCT03287375 2022-10-07
PIPAC-OPC2
Odense University Hospital
Phase 2 Completed
NCT03280511 2022-10-06
Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients
Odense University Hospital
Phase 2 Recruiting
NCT05353582 2022-04-29
Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases
Sun Yat-sen University
Phase 2 Unknown
NCT03352414 2021-08-18
ILEUS
University of California, San Diego
Phase 2 Terminated
NCT04797923 2021-03-15
A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination
Gangnam Severance Hospital
Phase 2 Unknown
NCT04734691 2021-02-02
OPAC
University Hospital, Geneva
Phase 2 Unknown
NCT00391118 2020-10-19
Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")
Eli Lilly and Company
Phase 2 Completed
NCT04475159 2020-07-17
Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial
Sheba Medical Center
Phase 2 Unknown
NCT03246321 2019-10-15
CRC-PIPAC
Catharina Ziekenhuis Eindhoven
Phase 2 Completed
NCT01833832 2019-07-30
Surgery and Heated Chemotherapy for Adrenocortical Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01523678 2019-07-10
Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers
Belgian Gynaecological Oncology Group
Phase 2 Completed
NCT03150628 2019-04-17
CISCA
UMC Utrecht
Phase 2 Terminated
NCT03161041 2018-11-14
Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis French Part of the Main Bev-IP Study
Hospices Civils de Lyon
Phase 2 Withdrawn
NCT00326885 2018-10-17
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
Neovii Biotech
Phase 2 Completed
NCT01540344 2018-09-05
COMBATAC
University of Regensburg
Phase 2 Terminated
NCT01504256 2018-01-23
CatuNeo
AIO-Studien-gGmbH
Phase 2 Completed
NCT02320448 2017-09-12
Treating Peritoneal Carcinomatosis With PIPAC
Odense University Hospital
Phase 2 Completed
NCT02739698 2017-08-01
Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia
Maimónides Biomedical Research Institute of Córdoba
Phase 2 Completed
NCT01095523 2017-07-02
Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT01681368 2017-05-30
Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT02638051 2017-05-19
OTMA-RII
Galenic Research Institute Ltd
Phase 2 Completed
NCT00352755 2016-12-13
A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis
Washington University School of Medicine
Phase 2 Terminated
NCT01342653 2016-11-21
HIPEC
Hospital General Universitario Gregorio Marañon
Phase 2 Suspended
NCT00112086 2016-08-31
OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206
Japan Clinical Oncology Group
Phase 2 Completed
NCT01116791 2015-12-02
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer
University Hospital, Gasthuisberg
Phase 2 Terminated